Medicare Advantage now covers more than 35 million people, 55% of eligible Medicare beneficiaries in 2026, drawn by $0 premiums, built-in dental and vision benefits, and a federally capped out-of-pocket maximum. Federal watchdogs, including MedPAC and the HHS Office of Inspector General, have also documented billions of dollars in overpayments and coverage denials that would have been approved under Original Medicare, raising a genuine ethics question: does the private-plan model that lowers costs and adds benefits for individual beneficiaries also shift cost and risk onto the Medicare Trust Fund and the patients least able to appeal a denial?
CoveredUSA breaks down the specific trade-offs with 2026 numbers: what Original Medicare and Medicare Advantage each guarantee, what MedPAC and the HHS Office of Inspector General have found about overpayments and denials, and what alternatives exist if the trade-offs described here do not fit your situation. See Medicare Advantage vs Original Medicare for a side-by-side benefits comparison and Medigap vs Medicare Advantage for the supplemental-insurance path.
Coverage Breakdown
| Plan Type | Provider Network Freedom | Prior Authorization Exposure | Extra Benefits (Dental/Vision/Hearing) | 2026 Out-of-Pocket Cap |
|---|---|---|---|---|
| Original Medicare | Any provider accepting Medicare nationwide | Rarely required outside a short CMS list | Not covered; requires separate policy | None without Medigap; unlimited 20% coinsurance exposure |
| Medicare Advantage (HMO/PPO) | Limited to plan network; referrals often required | Required for many imaging, post-acute, and specialty services | Usually included: dental, vision, hearing, fitness allowance | Capped at $9,250 in-network (CMS statutory max) |
| Medigap + Original Medicare | Any provider accepting Medicare nationwide | Rare; follows Original Medicare rules | Not added by Medigap; requires separate policy | Effectively the annual Part B deductible ($283) with Plan G |
| Medicare Advantage D-SNP (dual-eligible) | Limited network with required care coordination | Required, typically paired with a case manager | Enhanced extras for dual-eligible members | $9,250 in-network cap; Medicaid absorbs most cost-sharing |
Status reflects how each dimension applies to the plan type, not a value judgment on whether it is good or bad. CMS sets the 2026 in-network out-of-pocket cap at $9,250 ($13,900 combined in-network and out-of-network). Medigap policies cannot be combined with Medicare Advantage.
Source: CMS Medicare Advantage 2026 rules, Medicare.gov, KFF Medicare Advantage 2026 Spotlight
Direct Answer: It Depends on What You're Weighing
It depends on what you value most. Medicare Advantage trades network freedom for lower premiums, a $9,250 2026 out-of-pocket cap, and extra benefits like dental and vision. In exchange, plans require prior authorization for many services, and MedPAC estimates the government overpays Medicare Advantage insurers about $76 billion in 2026 versus Original Medicare costs. The ethics depend on weighing your costs against taxpayer cost, denial risk, and network limits.
What Original Medicare Offers Instead
Original Medicare gives beneficiaries the widest possible choice of doctors and hospitals nationwide, covering hospital care under Medicare Part A and outpatient physician services under Medicare Part B without a network to navigate. Any provider who accepts Medicare assignment must treat a Medicare patient at the same rate anywhere in the country, so beneficiaries who travel or split time between states never lose access. Original Medicare rarely requires prior authorization, and CMS restricts its use to a short list of outpatient procedures historically flagged for overuse.
The trade-off is cost exposure. Original Medicare has no annual cap on Part A and Part B cost-sharing, so most beneficiaries buy a Medigap policy or enroll in a retiree plan to limit that risk, adding a monthly premium of roughly $100 to $300 on top of the 2026 Part B premium of $202.90. Outside your one-time 6-month Medigap open enrollment window, insurers in most states can medically underwrite applicants and deny coverage or charge more for a preexisting condition, an access trade-off of its own.
What Medicare Advantage Trades In Return
Medicare Advantage plans bundle Medicare Part A, Part B, and usually Medicare Part D drug coverage into one private plan, often for a $0 monthly premium, and add benefits Original Medicare does not cover at all: dental cleanings, eyeglasses, hearing aids, over-the-counter allowances, and fitness memberships. CMS caps every Medicare Advantage plan's in-network out-of-pocket spending at $9,250 in 2026 ($13,900 combined in-network and out-of-network), a real financial backstop Original Medicare does not offer on its own. KFF reports that 55% of eligible Medicare beneficiaries, over 35 million people, chose Medicare Advantage for 2026.
Medicare Advantage insurers pay for these extras and the out-of-pocket cap in part by managing utilization more tightly than Original Medicare. Most plans restrict beneficiaries to an HMO or PPO network, require referrals to see specialists, and use prior authorization before approving many imaging tests, post-acute stays, and procedures. Supporters describe this as coordinated care that avoids waste; critics describe it as a structural incentive for the insurer, which keeps whatever premium it does not spend on care, to deny or delay services.
The Core Ethical Trade-offs, in the Data
MedPAC, the independent commission that advises Congress on Medicare payment, estimated in its March 2026 report to Congress that Medicare Advantage plans will be overpaid by about $76 billion in 2026, meaning CMS spends roughly 14% more per Medicare Advantage enrollee than it would if that same person stayed in Original Medicare. Part of that gap traces to risk-adjustment coding intensity, diagnosing patients with more billable conditions than Original Medicare typically records for a similar patient, which MedPAC now estimates adds about $22 billion (4%) to 2026 spending even after CMS phased in a stricter risk-adjustment model known as V28. Critics argue this shifts cost from Medicare Advantage insurers' shareholders onto the Medicare Trust Fund and every taxpayer; the insurance industry argues the difference partly reflects Medicare Advantage enrollees genuinely needing more documented care.
Prior authorization is the second flashpoint. A 2022 HHS Office of Inspector General audit of the 15 largest Medicare Advantage insurers found that 13% of denied prior authorization requests, and 18% of denied payment requests, actually met Medicare's own coverage rules and should have been approved, most often for advanced imaging like MRIs and post-acute rehabilitation stays. Supporters of Medicare Advantage counter that prior authorization also blocks unnecessary care and controls the cost growth that funds lower premiums for every enrollee; critics counter that a for-profit insurer approving or denying its own members' care is a structural conflict of interest that Original Medicare, with no prior authorization gatekeeper and no profit motive on the individual claim, does not share.
Medicare pays quality bonuses to any Medicare Advantage plan rated 4 stars or higher, and KFF projects those bonus payments will exceed $13.4 billion in 2026, even though the average Medicare Advantage plan is rated just 3.98 stars and MedPAC has repeatedly flagged the star-rating formula as an unreliable quality signal because it is calculated at the contract level rather than the individual plan level. CMS has also tightened Medicare Advantage marketing rules since 2022 after complaints about misleading television ads and commission-driven broker steering, and researchers have documented that sicker, more expensive Medicare Advantage enrollees disproportionately switch back to Original Medicare near the end of life, a pattern some economists describe as favorable selection working against the public program's finances.